Chermside, Australia Clinical Trials

A listing of Chermside, Australia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 386 clinical trials
Mindfulness Meditation Versus Clinical Hypnosis for Acute Experimental Pain

This trial aims to determine the effects and mechanisms (mediators and moderators) of brief training in mindfulness meditation versus clinical hypnosis on acute, experimental pain.

The University of Queensland
 (7.8 away) Contact site
  • 0 views
  • 15 May, 2021
  • 1 location
Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

MetFlex is an investigator led, open-label, single-arm, Phase 2a trial to determine the safety and tolerability of trimetazidine for the treatment of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND).

riluzole
motor neuron disease
primary lateral sclerosis
pregnancy testing
Royal Brisbane & Women's Hospital
 (4.2 away) Contact site
  • 0 views
  • 05 Sep, 2021
  • +2 other locations
Cystic Fibrosis - Insulin Deficiency Early Action

Cystic Fibrosis (CF) is the most common life-threatening genetic condition affecting Australian children. As well as repeated lung infections, children with CF develop insulin deficiency and eventually diabetes. The CF-IDEA trial (Cystic Fibrosis - Insulin Deficiency, Early Action) will determine whether starting insulin treatment before the onset of diabetes (earlier …

malnutrition
oral glucose tolerance test
blood glucose monitoring
antibiotic therapy
pulmonary function test
Lady Cilento Children's Hospital
 (6.6 away) Contact site
  • 50 views
  • 27 Sep, 2021
  • +5 other locations
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma

This is an international multicenter, open-label, sequential phase study of intralesional (IL) PV-10 in combination with immune checkpoint inhibition. Metastatic melanoma patients (Stage IV or Stage III unresectable, in-transit or satellite disease) with at least one injectable lesion who are candidates for pembrolizumab (both treatment nave patients and treatment refractory …

ct scan
pembrolizumab
EGFR
neutrophil count
platelet count
Princess Alexandra Hospital
 (7.6 away) Contact site
  • 78 views
  • 19 Jul, 2021
  • +7 other locations
Vincristine Sulfate Liposome Injection (Marqibo ) in Combination With UK ALL R3 Induction Chemotherapy for Children Adolescents and Young Adults With Relapsed ALL

This is a pilot study utilizing Marqibo (vincristine sulfate liposome injection) combined with dexamethasone, mitoxantrone and asparaginase (UK ALL R3) for relapsed acute lymphoblastic leukemia (ALL).

minimal residual disease
left ventricular fractional shortening
philadelphia chromosome
rituximab
lymphoma
Lady Cilento Children's Hospital
 (6.3 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +32 other locations
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

The primary objectives of this study are: To investigate the safety and tolerability, and to define the recommended Phase 2 dose and schedule (RP2DS) for magrolimab in combination with rituximab and for magrolimab in combination with rituximab, gemcitabine, and oxaliplatin (R-GemOx). To evaluate the efficacy of magrolimab in combination with …

gemcitabine
b-cell lymphoma
rituximab
follicular lymphoma
combination chemotherapy
Princess Alexandra Hospital
 (7.6 away) Contact site
  • 166 views
  • 26 Sep, 2021
  • +33 other locations